Abstract
Dose loading effects upon the peformance of 57Co-bleomycin as a tumor localizing agent have been investigated in Rhabdomyosarcoma bearing Wag/Ry rats. The addition of non-radioactively labelled Co-bleomycin increased the relative uptake of 57Co-bleomycin in rapid growing tumors, but the addition of non-chelated bleomycin had no influence at all. In our experimental system, iodinated bleomycin generally labelled by reaction with ICl, was found to be an unsatisfactory tumor localizing agent. In order to combine the useful localizing properties of Co-bleomycin with the qualified detection properties of some iodine isotopes, we attempted to prepare bleomycin doubly labelled with Co and I. However, we were unable to prepare 57Co-125I-bleomycin by general labelling with ICl. This result indicates that both labels need the imidazole ring for the formation of a stable, labelled bleomycin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Asakura, H., Umezawa, H., Hori, M.: DNA structures required for bleomycin binding. J. Antibiol. 31, 156 (1978)
Dabrowiak, J.C., Greenaway, F.T., Longo, W.E., Van Husen, M., Crook, S.T.: A spectroscopic investigation of the metal binding sites of bleomycin A2. The copper (II) and zinc (II) derivatives. Biochem. Biophys. Acta 517, 517 (1978)
DeNardo, G.L., DeNardo, S.J., Meyers, J., Krohn, K.A.: Tumor localization in animals and patients using radioiodinated bleomycin. J. Nucl. Med. 16, 524 (1975)
Eckelman, W.C., Kubota, H., Siegel, B.A., Komai, T., Rzeszotarski, W.J., Reba, R.C.: Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization. J. Nucl. Med. 17, 385 (1976)
Helmkamp, R.W., Contreras, M.A., Bale, W.F.: 131J-labeling of proteins by the iodine monochloride method. Int. J. Applied Rad. Isotop. 18, 737 (1967)
Kakinuma, J., Orii, H.: Preparation, isolation and identification of bleomycin-57Co chelate with special reference to its chelate structure. In: 2nd Int. Symposium Radiopharm. Chemistry, Oxford, 1978, No. B6
Krohn, K.A., Meyers, J., DeNardo, G.L.: Comparison of J-bleomycin prepared by two methods: stability and pharmacokinetics in tumor-bearing mice. Radiology 122, 179 (1977)
Krohn, K.A., Freauff, S.J.: Site of iodination of bleomycin. In: nd2 Int. Symposium Radiopharm. Chemistry, Oxford, 1978, No. 20
Meyers, J., Krohn, K.A., DeNardo, G.L.: Preparation and chemical characterization of radioiodinated bleomycin. J. Nucl. Med. 16, 835 (1975)
Müller, W.E.G., Zahn, R.K.: The DNA-modifying bleomycin: Mode of action on DNA and the resulting effects. Res. Mol. Biol. 7, 5 (1976)
Neirinckx, R.D.: Cyclotron production of Ni-57 and Co-55 and synthesis of their bleo-complexes. Int. J. Applied. Rad. Isotop. 28, 561 (1977)
Nunn, A.D.: The relative stability of bleomycin metal complexes to metal exchange. Eur. J. Nucl. Med. 2, 53 (1977)
Van de Poll, M.A.P.C., Versluis, A., Rasker, J.J., Jurjens, H., Woldring, M.G.: Labeling of bleomycin with cobalt-57, indium-111, technetium-9im, mercury-197, lead-203 and copper-67. Nucl. Med. 15, 86 (1976)
Rasker, J.J., Van de Poll, M.A.P.C., Beekhuis, H., Woldring, M.G., Nieweg, H.O.: Some experience with 57Co-labeled bleomycin as a tumor-seeking agent. J. Nucl. Med. 16, 1058 (1975)
Umezawa, H., Suhara, Y., Takita, T., Maeda, K.: Purification of bleomycins. J. Antibiot. A19, 210 (1966)
Umezawa, H.: Chemistry and mechanism of action of bleomycin. Fed. Proc. 33, 2296 (1974)
Zalutsky, M.R., Friedman, A.M., Sullivan, J.C., Ruby, S.L., Rayudu, G.V.S.: Studies of tumor metabolism II. Mössbauer spectroscopy of 57Co-bleomycin. Int. J. Nucl. Med. and Biol. 4, 216 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vos, C.M., Westera, G., van der Jagt, P.J. et al. The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals. Eur J Nucl Med 4, 393–396 (1979). https://doi.org/10.1007/BF00263311
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00263311